• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICALE CIE INC VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICALE CIE INC VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION Back to Search Results
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Thrombosis/Thrombus (4440)
Date of Event 10/01/2024
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported a thrombosis occurred.During a left atrial appendage closure (laac) procedure, a versacross connect for laac kit was selected for use.During the procedure, the implanting physician requested a half dose heparin to be given to the patient.The transseptal was completed by the physician and requested the other half dose of heparin to be given.It was at this time that anesthesia stated they had not given any and will give the full dose.A thrombus was noted by the transesophageal echocardiogram (tee) physician on the end of the trusteer/versacross connect sheath/dilator.The physician suctioned the thrombus and the procedure was continued.The procedure was successfully competed with the closure device implanted in the laa of the patient.The patient woke up neurologically intact and is expected to be discharged home the next day.The device is not expected to be returned for analysis.The physician attributes the thrombus formation due to the delay in heparin being given and a non-therapeutic activated clotting time (act) once to the left side of the heart.There was no difficulty noted with transseptal puncture or any malfunctions noted with versacross device.
 
Additional Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Common Device Name
DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION
Manufacturer (Section D)
BAYLIS MEDICALE CIE INC
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
angela hinkley
4100 hamline avenue north
dc a330
saint paul, MN 55112
6514400979
MDR Report Key20507260
Report Number2124215-2024-66111
Device Sequence Number8380852
Product Code DRE
UDI-Device Identifier00685447012597
UDI-Public00685447012597
Combination Product (Y/N)N
Initial Reporter StateAZ
Initial Reporter CountryUS
PMA/510(K) Number
K220414
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 10/22/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/01/2024
Initial Report FDA Received Date10/22/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-